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Abstract
In vitro stimulation of CD34+ cells with IL-2 induces NK cell differentiation. In order to define the
stages of NK cell development, which influence their generation from CD34 cells, we cultured G-
CSF mobilized peripheral blood CD34+ cells in the presence of stem cell factor and IL-2. After
three weeks culture we found a diversity of CD56+ subsets which possessed granzyme A, but
lacked the cytotoxic apparatus required for classical NK-like cytotoxicity. However, these CD56+
cells had the unusual property of inhibiting proliferation of K562 and P815 cell lines in a cell-contact
dependent fashion.
Introduction
NK cells are key mediators of innate immunity contribut-
ing to immunosurveillance by recognizing and killing
tumor and virus-infected cells. They are cytolytic and pro-
duce inflammatory cytokines [1,2]. Mature NK cells are
CD3-CD56+ and variably CD16+. The molecule CD56 is
a 120–180 KD N-linked glycosylated isoform of the neu-
ral cell adhesion molecule (NCAM) [3]. It is expressed on
NK cells, NK-T cells, and a subset of dendritic cells. NK
cells originate in the bone marrow from a CD34+Lin-
common lymphoid progenitor cells [4]. In the absence of
bone marrow stroma, NK cell generation requires a com-
bination of IL-2 or IL-15 [5,6] and stem cell factor (SCF)
[7]. However, the early stages of CD56+ cell generation
and the origin of diversification into mature CD56+ cell
types are not well characterized.
We previously found that in culture with IL-2 and SCF
CD34+ cells differentiate into several CD56+ subpopula-
tions – a minor myeloid subset consisting of large
CD56dim CD33+ macrophage-like cells and a major lym-
phoid subset of CD56bright cells. Both cell types had low or
absent perforin and no granzyme B [8]. In studying the
function of immature CD56+ cells, we observed that they
had negligible cytotoxicity. Here we describe a novel cell-
contact dependent proliferation inhibition of cell lines by
cultured CD56+ cells which suggests that immature
CD56+ cells may have novel growth regulatory properties.
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Materials and methods
Antibodies and reagents
Fluoroscein isothiocyanate (FITC)-conjugated anti-CD56,
anti-CD16, anti-CD33, anti-CD3, anti-CD2, anti-CD11a,
anti-CD94, anti-CD80, anti-CD44, anti-granzyme A, Allo-
phycocyanin (APC)-conjugated anti-CD56, anti-CD11c,
anti-CD38, anti-CD69, anti-CD117, (Pe)-conjugated
anti-CD117, NKB1 (KIR3DL1), anti-CD3, anti-CD16,
anti-CD56, anti-perforin, PerCP-conjugated anti-CD3,
anti-CD69, anti-CD8 and matching isotype mouse mAbs
were purchased from Becton and Dickinson (S Jose, CA).
Pe-conjugated anti-CD34, P58.1 (NK2DL1),
P58.2(NK2DL2), NKG2A were purchased from Immu-
notec (Marseille, France). Magnetic beads-conjugated
anti-CD56 and mini Macs magnet were purchased from
Miltenyi Biotec (Auburn, CA). (APC)-conjugated anti-
CD95 and (Pe)-conjugated anti-CD95L were purchased
from Caltag (Burlingame, CA). Hyaluronic acid was pur-
chased from Sigma (S Louis, Mo)
Cell isolation, activation and expansion
CD34+ cells were positively selected from normal donor
G-CSF-mobilized peripheral blood stem cells, (PBSC)
counted, and frozen in liquid nitrogen until use. All
donors gave written informed consent to donate stem
cells in NIH protocols 99-H-0046 and 95-H-0049. Periph-
eral blood mononuclear cells (PBMC) were separated by
Ficoll-hypaque density separation. Cells were cultured in
RPMI 1640 supplemented with 10% AB or 10% FCS
serum, glutamine (2 mM) gentamicin, hereafter referred
to as complete medium. CD34+ cells were cultured in
complete medium, in 24 or 12 or 96 U well plates (Cos-
tar), for a minimum of 10 to a maximum of 70 days. Cells
were stimulated every 5–7 days with SCF (20–50 ng/ml)
(Peprotech, Rocky Hill, NJ) with or without IL-2 (200 U/
ml) or IL-15 (1–100 ng/ml). To obtain pure NK popula-
tions, CD34+ cells stimulated for 15–21 day with IL-2
were stained with a Pe-conjugated anti-CD56 Moab and
CD56+ cells were isolated by electronic sorting using an
EPICS ALTRA Flow cytometer (Beckman Coulter, Miami,
FL). In some experiments, immature CD56+ cells were
selected with an anti-CD56 conjugated magnetic bead col-
umn (Miltenyi Inc.). Vigorous mechanical pressure eluted
the CD56+cells retained in the column. Peripheral blood
NK cells were negatively selected by magnetic sorting
using a Miltenyi isolation kit. Positively and negatively
selected peripheral blood NK cells were further expanded
in vitro as follows: 100 µl of 1 × 105 /ml CD56+ were
mixed with 100 µl of 75 Gy irradiated LCL cells in com-
plete medium supplemented with IL-2 (10 U/ml) and 15
% conditioning medium were plated in Costar 96/w
round bottom plates. Cells were stimulated every 3 days
with CM supplemented with 15% CM for the required
time.
Flow cytometric analysis
In some experiments, cells were stained with Pe-Conju-
gated anti-CD56 or anti-c-Kit (one color). In other exper-
iments, cells were incubated with FITC-anti-CD56 and Pe-
anti-c-Kit (two colors) or a combination of Pe, FITC,
PerCP, and APC-conjugated antibodies specific for the
desired molecules (four colors). In all cases the cells were
stained on ice, for 30 minutes, washed twice, fixed in 1%
paraformaldehyde (PFA). For intracellular staining exper-
iments (IC), 1 million cells were first stained with a Pe-
conjugated anti-CD56 for 15 minutes at room tempera-
ture (RT) in the dark than 2 ml of FACS lysing solution
was added to the cell mixture.
After 10 minutes incubation at RT, cells were washed and
permeabilized with 0.5 ml FACS perm mix for 10 minutes
at RT. Cells were than stained with an anti-Pe-conjugated
anti-Perforin Moab and a FITC-conjugated anti-granzyme
A moAb or Pe and FITC-conjugated mouse control moAb
isotypes for 30 minutes at RT, washed and fixed in 200 ul
of 1% PFA. Cells were analyzed by a 4 filters BD FACScan
Excalibur. For trans-well experiments, after an initial equi-
libration (1 hour at 37 C) with complete medium, 200 µl
of 5 × 104 - 1 × 105 CD34 cell- derived NK cells or IL-2 acti-
vated NK cells cultures were incubated in complete
medium in the upper trans-well compartment of a 12-
transwell plate (Costar, Cambridge, MA) in the presence
or absence of 5 × 103 - 5 × 104 K562, while 1 ml culture of
5 × 103K562 were cultured in the lower compartment. A
0.4  µm polycarbonate membrane separated upper and
lower compartments. After a 2-day incubation, aliquots of
200 µl of K562 cell culture were removed from the lower
compartment and labeled with 3H-TdR. Breaking and
washing the transmembrane then permitted harvesting
the upper compartment. Cells were counted or labeled
with 3H-TdR.
Microcytotoxicity assay
For reverse antibody-directed cell cytotoxicity (ADCC) 6
replicates of 20 µl of effector cells were incubated in a 60-
well (40 µl depth) Terasaki plate for 30 m at room temper-
ature in the presence or absence of 5 µl (10µg/ml) 3g8
(anti-CD16). At the same time, FcR+P815 (2 × 106) were
incubated in 1 ml of complete medium supplemented
with 10 µl of Calcein-AM (Molecular Probes, Junction
City, OR) for 30' at 37°C, washed four times and diluted
to 1 × 105/ml. After diluting the effector cells, 10 µl of tar-
get cells were added, plates were centrifuged and incu-
bated at 37°C for 4 hours. In some experiments, effectors
with no mAbs were challenged with K562 cells. A few
minutes before scanning the plates using a fluorescent
detector 5 µl fluoro-quench was added to each well. The
percent of lysis was calculated as follows: 1-(mean test-
mean blank)/(mean max-mean blank) ×100.Journal of Translational Medicine 2005, 3:15 http://www.translational-medicine.com/content/3/1/15
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Reverse transcriptase polymerase chain reaction
Total RNA was extracted from 1 × 106 positively selected
G-CSF-mobilized peripheral blood CD34+ cells, PBMC,
resting or IL-2 activated total peripheral blood CD56+
cells and NK cells using Triazol reagent; complementary
DNA (cDNA) first strand was produced using Maloney
murine leukemia reverse transcriptase (Roche) with an
oligo(dt)12–18 anti-sense primer (Roche). The cDNA of
interest was amplified as shown in table I. Amplified frag-
ments were analyzed in 1.5 % agarose gel electrophoresis
in the presence of ethidium bromide (Sigma, S Louis,
MO).
Proliferation assay
The proliferation of K562 and P815 was measured using
the tritiated thymidine incorporation (3H-TdR) assay. The
first three U-wells of each horizontal row of 96 well plates
were filled with 200 µl of negatively selected NK cells or
positively selected peripheral blood CD56+ cells, then
100 µl of cultured cells were serially diluted in the remain-
ing wells previously filled with 100 µl of CM. Later, 1 ×
104 K562 or P815 cells were added to the cell cultures.
After 2 days incubation, cells were pulsed with 1 µCi of
3H-TdR per well (Amersham Biosciences, Piscataway, NJ)
Eighteen hours later, 3H-TdR was measured using a beta
scintillation counter.
Results
Kinetics of CD56+ cell generation
After three weeks stimulation with IL-2 and SCF, G-CSF
mobilized peripheral blood CD34+ cells generated CD2-,
CD56high (10.6 ± 11.4) (range 3–39 %) and CD56low (3.4
± 2.0) (range 0.7–5 %) in a sample size of 7 normal
donors (REF). Some CD56high cells expressed CD94 and
Table 1: List of primers used in this study
Sequences
Sense Anti-Sense Transcript
Perforin cggctcacactcacagg ctgccgtggatgcctatg 369
Granzyme B ggggaagctccataaatgtcacct tacacacaagagggcctccagagt 431
NKp30 cagggcatctcgagtttccgacatggcctggatgctgttg gatttattggggtcttttgaag 606
NKp44 tacttcaaagtgtggcag tcacaaagtgtgttcatcatc 751
NKp46 aaaagcaagtgaccatct aagaacatgcttgttgcagt 337
NKp80 caagatgaagaaagataca gagaaccatccacccaagt 568
NKG2D gaaggcttttatccacaa ttacacagtcctttgcat 761
NKp30 NKG2D sense12, perforin and granzyme B11have been already described
Phenotypic analysis of G-CSF mobilized CD34+ cells cultured in SCF and IL-2 After 3 week stimulation with SCF (100 ng/ml)  and IL-2 (200 U/ml), G-CSF mobilized CD34+ cells were stained with for the indicated NK cell surface antigens using specific  moAb Figure 1
Phenotypic analysis of G-CSF mobilized CD34+ cells cultured in SCF and IL-2 After 3 week stimulation with SCF (100 ng/ml) 
and IL-2 (200 U/ml), G-CSF mobilized CD34+ cells were stained with for the indicated NK cell surface antigens using specific 
moAb.
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NKG2A but lacked expression of KIR with immunoglobu-
lin like domains KIR2DL2, while CD56low were KIR nega-
tive (Figure 1).
Immature CD56+ cells lack granzyme B and perforin
We next evaluated the stage of differentiation of mole-
cules associated with cytotoxicity in immature CD56+
cells. Perforin and granzyme B mRNA expression was
measured by RT-PCR in CD34+ cells stimulated with IL-2.
Perforin was observed on day 0–1 of culture, but disap-
peared by day 7. Intracellular staining of immature
CD56+ cells revealed a granzyme A content comparable to
that found in IL-2 activated PBL (Fig. 2). Notably, the
reduction of GAPDH band intensity may reflect loss of
viability of the cells upon medium term culture.
Induction of NKp46 in immature CD56+ cells
We then sought to determine whether the stimulation of
CD34+ cells with IL-2 and SCF induced NK natural cyto-
toxic receptor (NCR) expression. Within two week of cul-
ture, immature CD56+ cells expressed some NK activation
molecules including CD44, CD69, and CD38 (data not
shown) but did not express NCR genes until at least 6
weeks. At than time CD56+ cells expressed NKp46 but not
NKp30. Traces of NKG2D and NKP80 RNA expression
were also detected by PCR (Fig. 3).
Functional assays of CD56+ cells
IL-2 activated immature CD56+ cells showed negligible
cytotoxicity against K562 compared with the potent lysis
exhibited by peripheral blood NK cells. Similarly in a
reverse ADCC assay, immature CD56+ cells coated with
an anti-CD16 (3g8) showed only low cytotoxicity against
the FcR+ cell line, P815, while control peripheral blood
NK cells were strongly cytotoxic. We then investigated the
effect of CD56+ cells on proliferation of cell lines. Resting
CD34+ cells did not inhibit K562 proliferation, while
flow sorted, three week cultured CD56+ cells cultures
strongly inhibited K562 cell proliferation in a dose
dependent manner, reaching 90% inhibition at an E:T
ratio of 10:1. The proliferation inhibition induced by
immature CD56+ cells ranged between 29 and 96.5 %
(Table 2). Immature CD56+ cells also comparably inhib-
ited the proliferation of the NK resistant cell line P815,
indicating that the proliferation inhibition was independ-
ent of the resistance of this line to NK-mediated cytotoxic-
ity. Unlike immature CD56+ cells, peripheral blood-
derived CD56+ cells proliferated in the presence of IL-2.
Cytotoxic granule content of immature CD56+ cells Figure 2
Cytotoxic granule content of immature CD56+ cells: A. Absence of perforin and granzyme B in CD34+ cells incubated with IL-
2 and SCF for up to 15 days compared with control (representative of three experiments). B CD56+ cells from three week 
cultures showing presence of granzyme A but not perforin compared with control IL-2 stimulated PBL.Journal of Translational Medicine 2005, 3:15 http://www.translational-medicine.com/content/3/1/15
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Nevertheless the proliferation attributable to K562 cells
was also abolished when cultured with CD56+ cells (Fig.
4). Trans-well experiments were used to determine
whether the inhibition of K562 cell proliferation was
mediated by cell-interaction or by soluble factors. In three
experiments, the average 3H-TdR incorporation of K562
cells when separated by a membrane from immature
CD56+ cells was 5361 ± 1967 versus 5110 ± 1539 cpm for
Gene expression of NK activating molecules on CD34-derived CD56+ cells upon stimulation with SCF+IL-2 Figure 3
Gene expression of NK activating molecules on CD34-derived CD56+ cells upon stimulation with SCF+IL-2. CD34+ cells 
were stimulated with SCF and IL-2. At the indicated time, RNA was isolated. NK activating molecules mRNA gene expression 
was analyzed. By day 15 incubation 39% of CD56+ cells were detected by flow cytometry in the cell culture.Journal of Translational Medicine 2005, 3:15 http://www.translational-medicine.com/content/3/1/15
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K562 growth in the absence of CD56+ soluble factors.
This suggested that proliferation was primarily blocked by
cell-cell contact (Table 3). To further examine the mecha-
nism of K562 proliferation inhibition, we cultured K562
with either magnetically sorted immature CD56+ cells in
a transwell upper chamber and K562 cells in the lower
chamber for two days. Viable K562 cells (> 95% trypan
blue negative cells) were recovered from immature
CD56+ cells but not from mature CD56+ cultures. After
depleting the K562/immature CD56+ cultures of CD56+
cells using antibody-coated magnetic beads, residual
K562 cells again proliferated, indicating that in the
absence of cytotoxicity, proliferation inhibition was
reversible (data not shown).
Discussion
Prolonged culture of human CD34+ cells with IL-2 or IL-
15, with or without bone marrow stroma cells can gener-
ate cytotoxic CD56+ cells [9,5]. These cells are CD94+ and
NKG2A+ but it is not clear whether they express other
KIRs [9-11]. Here we studied the early stages of NK cell
generation from G-CSF mobilized CD34+ cells. After
three weeks stimulation with SCF+IL-2, we identified an
immature NK population of CD94+ NKG2A+ KIR-
CD56+ cells. We previously found that these immature
CD56+ populations are heterogeneous. Notably there is a
minor subset of CD56dim  CD33+ cells that may be
precursors to a novel population of CD56+ monocytes
[12]. The major CD56+ population with bright CD56+
Functional features of immature CD56+ cell upon SCF+IL-2 stimulation Figure 4
Functional features of immature CD56+ cell upon SCF+IL-2 stimulation. A, cytotoxicity of immature CD56+ cells (open 
squares) compared with IL-2 activated peripheral blood NK cells (closed circles). B. Cytotoxicity against P815 cells by imma-
ture CD56+ cells incubated with (open circles) or without 3G8 (open squares), compared with peripheral blood NK (closed 
symbols in the presence (closed triangles) or absence 3G8 (closed circles). This was a representative experiment of series of 
three. C Resting CD34+ cells (open squares) or IL-2 activated peripheral blood NK cells (open circles) were incubated at dif-
ferent ratio with K562. D. After 21 days stimulation with IL-2 and SCF, immature CD56+ cells were isolated from whole cells 
by electronic sorting and incubated in the absence (open squares) or presence (close squares) of K562. IL-2 activated periph-
eral blood NK cells were cultured in the absence (close circles) or presence (open circles) of K562 (representative of ten 
experiments). E. Inhibition of proliferation of the NK resistant cell line P815 by IL-2 activated peripheral blood NK cells (open 
circles) or with IL-2 activated peripheral blood NK cells (closed squares). Cells were then labeled with 3H-TdR and radioactiv-
ity (CPM) was measured by a β -counter (representative of three experiments).Journal of Translational Medicine 2005, 3:15 http://www.translational-medicine.com/content/3/1/15
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expression and lymphoid features include a c-Kit+
CD11a- cell and a more mature c-Kit- CD11a+subset. The
c-kit+ cell may be the precursor to the c-kit- cell which has
lost responsiveness to SCF and has acquired integrins nec-
essary for formation of effector-target conjugates and kill-
ing [13]. However, all these CD56+ subsets were
immature with respect to functioning cytotoxic apparatus.
Mature cytotoxic NK cells can be generated from CD34+
cells when cultured with an IL-15-producing human
spleen fibroblast cell line [14]. However, the generation of
fully functional NK cells takes many weeks of cell culture.
Using a stroma cell line stimulated with IL-15 Sivori et al
did not observe NK mediated cytotoxicity against K562
within the first of month culture. After one month, cells
exhibited cytotoxicity but remained KIR negative [15].
Similarly, in our experiments, long term culture induced
some mature NK markers – NKp46 and NKp80 gene
expression. However within the first month of culture
CD34-derived CD56+ cells exerted negligible cytotoxicity.
In the absence of any T, B or myeloid cell markers and
some NK marker (including NK activation markers CD38,
CD44, and CD69), we consider the major population of
CD56+ cells to be immature NK cells [16-19]. Their failure
to exert cytotoxicity is consistent with perforin and
granzyme B knock-out mouse models which lack cell-
mediated cytotoxicity, while granzyme A knock-out mice
retain cytotoxicity [20-22]. As a consequence, while
mature NK cells undergo functional anergy and apoptosis
on contact with K562 cells [23,24] mixed cultures of
immature CD56+ and K562 maintained cell numbers.
Because immature CD56+ cells produce a variety of
cytokines [6], we explored the possibility that they might
have functional properties other than cytotoxicity.
Remarkably, purified immature CD56+ cells strongly
Table 2: CD34-derived CD56+ cells inhibited K562 proliferation
3H-TdR (CPM)
ImmatureCD56+ cells + K562 K562 only % proliferation inhibition
1 214 6183.5 96.5
2 267 6183.5 95.7
3 8183 11172 27
41 8 0 5 5 2 8 3 6 6
51 9 4 4 . 5 4 7 2 05 9
6 743 11232 93.4
7 2708 10323 74
8 355 2524 86
9 138 2524 94.6
10 829 7336 89
Mean ± SD 1718.7 ± 2433.5 6748.1 ± 3255.5 78 ± 22.2
Electronically or magnetically sorted CD34-derived CD56+ cells and incubated 10:1 ratio with K562 and cell proliferation was evaluated after 2-day 
culture. The difference in the mean CPM incorporation between immature CD56+cells+K562 and K562 alone was highly significant with a P value 
of 0.0011. The range of CPM incorporation in the presence of immature CD56+ cells and K562 was 138–8103 while in the presence of K562 alone 
was 2524–11232.
Table 3: Transwell Experiments
3H-TDR (CPM)
*Immature CD56 **Mature CD56 ***K562
Exp 1 6781 ± 51 5941 ± 560 4429 ± 197
Exp 2 3116 ± 65 2534 ± 196 4030 ± 239
Exp 3 6187 ± 512 2932 ± 181 6873 ± 34
Sorted Immature * or mature CD56+ cells** or K562 were incubated 10:1 ratio in the upper chamber at of Transwell plates while K562 were 
incubated in the lower chamber. After 2 days, lower K562 were collected labeled overnight with 3H-TDR and analyzed in a β -counter 0.4 µm 
polycarbonate transwell membrane were removed and the upper compartment cells were harvested and evaluated for viability by trypan blue 
exclusion assay.Journal of Translational Medicine 2005, 3:15 http://www.translational-medicine.com/content/3/1/15
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inhibited proliferation of both K562 cells and the NK
resistant cell line P815 at low E:T ratios. The absence of
detectable perforin excluded the possibility that the effect
was due to contamination by a small population of sur-
viving NK cells. Maximum inhibition of proliferation was
only seen when effector-target contact occurred. This sug-
gests that immature CD56+ cells, while lacking cytotoxic-
ity, had a novel cell-contact dependent cytostatic effect.
Our findings support earlier observations suggesting that
bone marrow NK cells regulate hematopoiesis through a
non-cytotoxic pathway [25-28]. It is not clear what is the
mechanism utilized by immature CD56+ cells for K562
and P815 proliferation inhibition. Cell surface TGF-beta
expression on immature CD56+ cells may be responsible
for such inhibition since CD34+ cells upon SCF and IL-2
stimulation acquire TGF-beta gene expression (data not
shown).
In conclusion, we describe here early stages of NK cell gen-
eration from G-CSF mobilized CD34+ cells in the pres-
ence of SCF and IL-2. Although immature NK cells lack
the cytotoxic apparatus required for classical NK-like cyto-
toxicity they had the unusual property of inhibiting pro-
liferation of K562 and P815 cell lines. In our future
studies we are planning to assess whether the antiprolifer-
ative effects of immature CD56+ cells will also involve
cells of myeloid lineages and non hematopoietic cell
lines. It is possible that these cells normally reside in the
bone marrow and have a regulatory effect on
hematopoiesis
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